Ascendis Pharma A/S (ASND) Earnings Date & Reports
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients... Show more
ASND is expected to report earnings to fall 111.67% to 11 cents per share on February 12
Q4'25
Est.
$0.12
Q3'25
Missed
by $0.72
Q2'25
Beat
by $0.45
Q1'25
Missed
by $0.11
Q4'24
Beat
by $0.34
The last earnings report on November 12 showed earnings per share of -100 cents, missing the estimate of -28 cents. With 1.91M shares outstanding, the current market capitalization sits at 12.61B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ASND showed earnings on November 12, 2025. You can read more about the earnings report here.